Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single and Repeat Dosing Study of the Safety, Drug Exposure and Clinical Activity of R-2487 in Patients With Sjogren's Syndrome (SS)

NCT06297213 is registered in ClinicalTrials.gov with Rise Therapeutics LLC as lead sponsor.

NCT NCT06297213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06297213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single and Repeat Dosing Study of the Safety, Drug Exposure and Clinical Activity of R-2487 in Patients With Sjogren's Syndrome (SS)
Lead sponsor
Rise Therapeutics LLC
Phase
Phase 1
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
November 30, 2029
Enrollment
36 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sjogren's syndrome, sjögren, sjögren syndrome, unspecified